Merck
MRK
#51
Rank
โ‚น28.166 T
Marketcap
โ‚น11,404
Share price
-0.43%
Change (1 day)
65.67%
Change (1 year)

EPS for Merck (MRK)

EPS in 2026 (TTM): โ‚น303.66

According to Merck's latest financial reports the company's current EPS (TTM) is โ‚น340.65. In 2025 the company made an earnings per share (EPS) of โ‚น697.84 an increase over its 2024 EPS that were of โ‚น647.26.

EPS history for Merck from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)โ‚น303.66-56.49%
2025โ‚น697.847.81%
2024โ‚น647.264308.46%
2023โ‚น14.68-97.32%
2022โ‚น548.7010.92%
2021โ‚น494.6884.68%
2020โ‚น267.87-27.2%
2019โ‚น367.9363.44%
2018โ‚น225.11151.11%
2017โ‚น89.65-54.58%
2016โ‚น197.3630.21%
2015โ‚น151.57-61.99%
2014โ‚น398.72180.51%
2013โ‚น142.14-31.82%
2012โ‚น208.476.62%
2011โ‚น195.52

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
โ‚น836.59 145.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น672.24 97.34%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
โ‚น125.45-63.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
โ‚น345.56 1.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น2,703 693.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น1,387 307.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚น245.11-28.05%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
โ‚น340.91 0.07%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚น372.15 9.25%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
โ‚น131.19-61.49%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel